Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Huttner A, Bernasconi E, Viereck V, Kavvadias T, Kling K, Ryu G, Hülder T, Gröger S, Scheiner D, Alaimo C, Harbarth S, Poolman J, Kuhn A, de Vallière S, Hatz C, van den Dobbelsteen G, Abbanat D, Hornacek A, Frölich R, Dreyer A, Martin P, Davies T, Fae K, van den Nieuwenhof I, Thoelen S, Fonck V. Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial. Lancet Infect Dis 2017; 17:528-537.
Feb 24, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Feb 24, 2017
Lancet Infect Dis 2017; 17:528-537
Huttner Angela, Bernasconi Enos, Viereck Volker, Kavvadias Tilemachos, Kling Kerstin, Ryu Gloria, Hülder Tanja, Gröger Sabine, Scheiner David, Alaimo Cristina, Harbarth Stephan, Poolman Jan, Kuhn Anette, de Vallière Serge, Hatz Christoph, van den Dobbelsteen Germie, Abbanat Darren, Hornacek Alena, Frölich Rahel, Dreyer Anita M, Martin Patricia, Davies Todd, Fae Kellen, van den Nieuwenhof Ingrid, Thoelen Stefan, Fonck Veronica Gambillara
more
